NCT01229176View on ClinicalTrials.gov

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Typhoid Fever
Interventions
BIOLOGICAL

Vi-CRM197 vaccine

BIOLOGICAL

Vi Polysaccharide (PS) vaccine

BIOLOGICAL

Pneumococcal conjugate vaccine

Trial Locations (2)

74800

The Aga Khan University Hospital, Karachi

411011

K.E.M. Hospital Research Centre, Pune

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY